Aktis Oncology, Inc.

Preliminary trading in shares of US biotech company Aktis Oncology has started in the Freedom trading system for clients. The startup, in which pharma giant Eli Lilly and major industry investor MPM BioImpact have invested, develops drugs with radioactive isotopes to treat cancerous tumors. Later Friday, Aktis Oncology securities will appear on the Nasdaq exchange under the ticker AKTS.